NPS Pharmaceuticals (NPSP) News Today → Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad) Free NPSP Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineArena Pharmaceuticalsforbes.com - November 14 at 10:47 AMNPSP Historical Datainvesting.com - October 18 at 7:27 AMNPS Stock Gaps Down On Today's Open (NPSP)thestreet.com - March 31 at 7:42 PMHow to reclaim withdrawn but unclaimed amount from National Pension System (NPS) accountmsn.com - February 13 at 12:20 AMHow much money is held under National Pension System (NPS): State-wise data heremsn.com - December 15 at 1:12 PMNPS proposes systematic lump sum withdrawal plan for pensioners; invites suggestions till 19 Octobermsn.com - October 6 at 8:30 PMNPS Pharma: Bullish Options Trade Into the Gattex FDA Panelthestreet.com - September 21 at 10:07 AMNPS Calculator: Want Rs 75,000 monthly pension post retirement? Here’s how much you need to investmsn.com - September 9 at 1:39 PMEnzon and NPS Pharma Call Off Mergerthestreet.com - July 18 at 10:53 PMNPS Pension Calculator: Now you can get Rs 2 lakh per month, here's howmsn.com - June 28 at 5:07 AMCramer's 'Mad Money' Recap: The Winning Formulathestreet.com - May 4 at 9:07 PMKrispy Kreme Doughnuts (DNUT)forbes.com - February 20 at 7:39 PMEuropean Stocks Rebound as Pharma Deals Renew Confidencethestreet.com - January 7 at 4:53 AMCelgene and NPS Pharmaceuticals Shares Surge on Positive FDA Newsfinance.yahoo.com - October 26 at 1:29 AM Get NPS Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NPSP and its competitors with MarketBeat's FREE daily newsletter. Email Address Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad)If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.) Watch my video for all of the details NPSP Media Mentions By Week NPSP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NPSP News Sentiment▼0.000.41▲Average News Sentiment NPSP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NPSP Articles This Week▼00▲NPSP Articles Average Week Get NPS Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NPSP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NPSP) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe World's First "$20 Trillion Drug?"Behind the MarketsFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NPS Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
